Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (141-150 of 333) with videos related to

Pageof 34
Sort By:
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Nutrients|November 27, 2025
Joint Bacterial Traces in the Gut and Oral Cavity of Obesity Patients Provide Evidence for Saliva as a Rich Microbial Biomarker SourceJacqueline Rehner, Madline Gund, Sören L Becker, et al.
JHEP Reports : Innovation in Hepatology|September 1, 2021
Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosisElisabeth Erhardtsen, Daniel G K Rasmussen, Peder Frederiksen, et al.
Scientific Reports|November 27, 2019
Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver diseaseMuhammad Ashfaq-Khan, Misbah Aslam, Muhammad Asif Qureshi, et al.
Journal of the American Medical Informatics Association : JAMIA|March 8, 2021
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitisMatt Docherty, Stephane A Regnier, Gorana Capkun, et al.
AIDS Care|February 7, 2013
Disclosure behaviour and experienced reactions in patients with HIV versus chronic viral hepatitis or diabetes mellitus in GermanyJ M Kittner, F Brokamp, B Jäger, et al.
BMC Gastroenterology|February 5, 2025
Collagen turnover biomarkers to predict outcome of patients with biliary cancerLeonard Kaps, Muhammed A Genc, Markus Moehler, et al.
Hepatology (Baltimore, Md.)|August 18, 2023
The global fatty liver disease Sustainable Development Goal country score for 195 countries and territoriesJeffrey V Lazarus, Hannah Han, Henry E Mark, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2013
Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agentsJens M Kittner, Nora M Weiss, Jörg Wiltink, et al.
Journal of Human Genetics|February 28, 2018
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centersMarcin Krawczyk, Heike Bantel, Monika Rau, et al.
Pageof 34

Showing results (141-150 of 333) with videos related to

Sort By:
Pageof 34
Hepatology Communications|April 12, 2022
Effect of hepatic steatosis and associated metabolic comorbidities on health-related quality of life in people living with HIVMaurice Michel, Christian Labenz, Malena Anders, et al.
Nutrients|November 27, 2025
Joint Bacterial Traces in the Gut and Oral Cavity of Obesity Patients Provide Evidence for Saliva as a Rich Microbial Biomarker SourceJacqueline Rehner, Madline Gund, Sören L Becker, et al.
JHEP Reports : Innovation in Hepatology|September 1, 2021
Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosisElisabeth Erhardtsen, Daniel G K Rasmussen, Peder Frederiksen, et al.
Scientific Reports|November 27, 2019
Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver diseaseMuhammad Ashfaq-Khan, Misbah Aslam, Muhammad Asif Qureshi, et al.
Journal of the American Medical Informatics Association : JAMIA|March 8, 2021
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitisMatt Docherty, Stephane A Regnier, Gorana Capkun, et al.
AIDS Care|February 7, 2013
Disclosure behaviour and experienced reactions in patients with HIV versus chronic viral hepatitis or diabetes mellitus in GermanyJ M Kittner, F Brokamp, B Jäger, et al.
BMC Gastroenterology|February 5, 2025
Collagen turnover biomarkers to predict outcome of patients with biliary cancerLeonard Kaps, Muhammed A Genc, Markus Moehler, et al.
Hepatology (Baltimore, Md.)|August 18, 2023
The global fatty liver disease Sustainable Development Goal country score for 195 countries and territoriesJeffrey V Lazarus, Hannah Han, Henry E Mark, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2013
Defer or treat? Reasons for treatment decisions in patients with chronic hepatitis C genotype 1 in the early era of directly acting antiviral agentsJens M Kittner, Nora M Weiss, Jörg Wiltink, et al.
Journal of Human Genetics|February 28, 2018
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centersMarcin Krawczyk, Heike Bantel, Monika Rau, et al.
Pageof 34